Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126233791 | 12623379 | 1 | I | 20150617 | 20160804 | 20160804 | EXP | US-ACTELION-A-NJ2015-119957 | ACTELION | 79.00 | YR | E | F | Y | 0.00000 | 20160804 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126233791 | 12623379 | 1 | PS | TRACLEER | BOSENTAN | 1 | Oral | 62.5 MG, BID | DP033P0101 | 21290 | 62.5 | MG | TABLET | BID | |||||
| 126233791 | 12623379 | 2 | C | RIOCIGUAT | RIOCIGUAT | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126233791 | 12623379 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126233791 | 12623379 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126233791 | 12623379 | Arthralgia | |
| 126233791 | 12623379 | Gait disturbance | |
| 126233791 | 12623379 | Haemarthrosis | |
| 126233791 | 12623379 | Joint effusion | |
| 126233791 | 12623379 | Joint swelling | |
| 126233791 | 12623379 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |